1.
Alice Scemama, Sophia Lunetto, Artysha Tailor, et al. Hybrid Cancer Stem Cells Utilise Vascular Tracks for Collective Streaming Invasion in a Metastasis-on-a-Chip Device.; 2024. doi:10.1101/2024.01.02.573897
Cancer
1.
Fei Tian, Dong Liu, Na Wei, et al. Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning. Nature Medicine. 2024:1-11. doi:10.1038/s41591-024-02915-w
1.
Anthony J. Wilby, Sara Cabral, Nastaran Zoghi, Sacha J. Howell, Gillian Farnie, Hannah Harrison. A novel preclinical model of the normal human breast. Journal of Mammary Gland Biology and Neoplasia. 2024;29(1):9. doi:10.1007/s10911-024-09562-4
1.
Haonan Song, Haoyuan Jiang, Weichu Hu, et al. Cervical extracellular matrix hydrogel optimizes tumor heterogeneity of cervical squamous cell carcinoma organoids. Science Advances. 2024;10(20):eadl3511. doi:10.1126/sciadv.adl3511
1.
Tengku Ibrahim Maulana, Claudia Teufel, Madalena Cipriano, et al. Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells. Cell Stem Cell. 2024;31(7):989-1002.e9. doi:10.1016/j.stem.2024.04.018
1.
Hojjatollah Nazari, Ann-Na Cho, Dale Goss, Jean Paul Thiery, Majid Ebrahimi Warkiani. Impact of brain organoid-derived sEVs on metastatic adaptation and invasion of breast carcinoma cells through a microphysiological system. Lab on a Chip. 2024;24(14):3434-3455. doi:10.1039/D4LC00296B
1.
Arianna Fedi, Chiara Vitale, Marco Fato, Silvia Scaglione. A Human Ovarian Tumor & Liver Organ-on-Chip for Simultaneous and More Predictive Toxo-Efficacy Assays. Bioengineering. 2023;10(2):270. doi:10.3390/bioengineering10020270
1.
Eliana Steinberg, Roy Friedman, Yoel Goldstein, et al. A fully 3D-printed versatile tumor-on-a-chip allows multi-drug screening and correlation with clinical outcomes for personalized medicine. Communications Biology. 2023;6(1):1-14. doi:10.1038/s42003-023-05531-5
1.
Xuexue Xie, Xinyu Li, Wei Song. Tumor organoid biobank-new platform for medical research. Scientific Reports. 2023;13(1):1819. doi:10.1038/s41598-023-29065-2
1.
Laura Rüland, Francesco Andreatta, Simone Massalini, et al. Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss. Nature Communications. 2023;14(1):2377. doi:10.1038/s41467-023-37951-6